Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,842Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M89.4EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.7PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M32,400,032ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XBIFirst Eagle Investment 2016-03-31 Buy $45.73 - $70.2
($52.16)
$ 56.849%New holding18,150
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XBI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Atkinson, Richard Collier10% Security Holder 2016-05-06Buy169,000$0.0869925view
Reeson, DouglasDirector, Senior Officer 2016-05-06Buy100,000$0.03186633.33view
Crossett, Paul Everett10% Security Holder 2016-05-06Buy61,000$155-63.86view
Bal, Jatinder SinghIssuer 2016-05-06Sell20,000$0.0693266.67view
Bowerman, GordonDirector 2016-05-05Buy5,000$1.075135.51view
Yamini, BahmanDirector, Senior Officer 2016-05-03Buy5,000$0.2324256.52view
Buskard, James LivingstoneSenior Officer 2016-05-02Sell50,000$0.5510085.45view
Bal, Jatinder SinghDirector 2016-05-02Sell125,000$0.155920view
Bal, Jatinder SinghIssuer 2016-05-02Sell30,000$0.05111940view
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.992715.08view

Quarterly/Annual Reports about XBI:

    News about XBI:

    Articles On GuruFocus.com
    Value Investing in BioPharma Nov 18 2015 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    Markets Rise as Fed Member James Bullard Exhibits Hawkish Stance May 23 2016
    XBI Large-Caps: Why Is BioMarin Inching Higher? May 19 2016
    Markets Are Defensive: XBI Outperforms the Market May 19 2016
    Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead May 17 2016
    Analyzing XBI Mid-Caps: Intrexon Fell Due to 1Q16 Loss May 16 2016
    What Do Analysts Recommend for Medivation? May 16 2016
    What Lies Ahead for Biotech ETFs? May 13 2016
    Inside XBI Large-Caps: European Commission Approves of Empliciti May 12 2016
    XBI Dropped, Markets Fell Due to Retail Sector Concerns May 12 2016
    Why Did Medivation’s Share Price Increase so Much after Earnings? May 10 2016
    The Trader Daily: Lots of Stocks Get Drilled May 10 2016
    Healthcare, Biotech SPDR Indexes Gain on May 9 as US Dollar Rises May 09 2016
    IHI Bucks the Downward Trend for the Week Ending May 6 May 09 2016
    Inside XBI’s Mid Caps: Ionis Crashes on 1Q16 Earnings Report May 06 2016
    Inside XBI’s Large Caps: Incyte Pulls Down Large Caps on Earnings Concerns May 05 2016
    How beaten-up Mr. Market still could rise up to a new high May 05 2016
    Inside Soliris’s Continued Growth Momentum May 04 2016
    [$$] Sarepta: A High-Risk, High-Return Trade May 04 2016
    XBI’s Mid Caps: Ionis Gives Update on Nusinersen Phase 2 Study May 04 2016
    Ionis’s Metabolic Segment: Phase I and Phase II Studies May 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)